Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Director departure

Hoth Therapeutics, Inc. (HOTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/18/2023 4 Sarnoff David (Director) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 7,500 options @ $2.59, valued at $19.4k
07/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2023 4 Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 40,000 options @ $2.59, valued at $103.6k
07/18/2023 4 Pavell Jeff (Director) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 7,500 options @ $2.59, valued at $19.4k
07/18/2023 4 Linsley Wayne (Director) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 7,500 options @ $2.59, valued at $19.4k
12/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/13/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
09/20/2022 4 Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Bought 10,000 shares @ $0.39, valued at $3.9k
09/19/2022 4 Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Bought 10,000 shares @ $0.4, valued at $4k
03/18/2022 4 Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 500,000 options @ $0.591, valued at $295.5k
03/18/2022 4 Johns Stefanie (Chief Scientific Officer) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 250,000 options @ $0.591, valued at $147.8k
03/18/2022 4 Sarnoff David (Director) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 40,000 options @ $0.591, valued at $23.6k
03/18/2022 4 Springer Graig (Director) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 40,000 options @ $0.591, valued at $23.6k
Granted 250,000 options @ $0.591, valued at $147.8k
03/18/2022 4 Linsley Wayne (Director) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 40,000 options @ $0.591, valued at $23.6k
02/16/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 225,000 options @ $2.11, valued at $474.8k
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/09/2020 3 Johns Stefanie (Chief Scientific Officer) has filed a Form 3 on Hoth Therapeutics, Inc.
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 4 Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 80,000 options @ $3.05, valued at $244k
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/29/2020 4 Hayes Anthony (10% Owner) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Sold 400,000 shares @ $1.25, valued at $500k
04/17/2020 4 Linsley Wayne (Director) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 3,333 shares @ $0
04/17/2020 3 Linsley Wayne (Director) has filed a Form 3 on Hoth Therapeutics, Inc.
04/16/2020 4 Springer Graig (Director) has filed a Form 4 on Hoth Therapeutics, Inc.
Txns: Granted 3,333 shares @ $0
03/04/2020 3 Springer Graig (Director) has filed a Form 3 on Hoth Therapeutics, Inc.
12/26/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy